Stamatopoulos, K.; Mistry, N.; Fotaki, N.; Turner, D.B.; Swift, B.
Physiologically Based Biopharmaceutics Model (PBBM) of Minimally Absorbed Locally Acting Drugs in the Gastrointestinal Tract—Case Study: Tenapanor. Pharmaceutics 2023, 15, 2726.
https://doi.org/10.3390/pharmaceutics15122726
AMA Style
Stamatopoulos K, Mistry N, Fotaki N, Turner DB, Swift B.
Physiologically Based Biopharmaceutics Model (PBBM) of Minimally Absorbed Locally Acting Drugs in the Gastrointestinal Tract—Case Study: Tenapanor. Pharmaceutics. 2023; 15(12):2726.
https://doi.org/10.3390/pharmaceutics15122726
Chicago/Turabian Style
Stamatopoulos, Konstantinos, Nena Mistry, Nikoletta Fotaki, David B. Turner, and Brandon Swift.
2023. "Physiologically Based Biopharmaceutics Model (PBBM) of Minimally Absorbed Locally Acting Drugs in the Gastrointestinal Tract—Case Study: Tenapanor" Pharmaceutics 15, no. 12: 2726.
https://doi.org/10.3390/pharmaceutics15122726
APA Style
Stamatopoulos, K., Mistry, N., Fotaki, N., Turner, D. B., & Swift, B.
(2023). Physiologically Based Biopharmaceutics Model (PBBM) of Minimally Absorbed Locally Acting Drugs in the Gastrointestinal Tract—Case Study: Tenapanor. Pharmaceutics, 15(12), 2726.
https://doi.org/10.3390/pharmaceutics15122726